


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
BBOT
BridgeBio Oncology Therap
$8.81

Login to see BridgeBio Oncology Therap (BBOT) Stock IQ rating
Get instant clarity on whether to Buy, Hold, or Avoid.
Strengths

Outperform the market

Upgraded on attractively valued

Earnings are forecast to grow
BBOT Price Performance
$8.79 (+0.23%)
$10.3 (-14.47%)
$12.33 (-28.55%)
$8.94 (-1.45%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Outperform the market
Earnings are forecast to grow
BBOT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BBOT Street Sentiment is bullish and have positive views on the near-term outlook
BBOT has Low risk level

Sentiments overview associated with events and the stock performance
Recent Upgrades and Downgrades
Nov 26, 2025
Reiterate
Outperform
Wedbush
Dec 12, 2025
Reiterate
Outperform
Wedbush
Mar 11, 2026
Initiate
Outperform
William Blair
Jan 10, 2026
Initiate
Outperform
Raymond James
Apr 08, 2026
Reiterate
Overweight
Barclays
BBIO
BridgeBio Pharma Inc
68.22
+3.36%
ARWR
Arrowhead Pharmaceuticals
77.14
+5.41%
What is BBOT current stock price?
What is BBOT current Stock IQ?
What is BBOT RSI signal right now?
What is BBOT analyst price target and upside potential?
What do analysts say about BBOT stock?
What is BBOT momentum trend right now?
What are BBOT stock strengths?
What is BBOT Risk Level?
Should I buy BBOT stock right now?
Is BBOT a Strong Buy right now?
What is BBOT market cap and volume?
What factors influence BBOT's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
BBOT
BridgeBio Oncology Therap
Current Price
$8.81
BBIO
BridgeBio Pharma Inc
68.22
+3.36%
ARWR
Arrowhead Pharmaceuticals
77.14
+5.41%

BBOT Price Performance
$8.79 (+0.23%)
$10.3 (-14.47%)
$12.33 (-28.55%)
$8.94 (-1.45%)
BBOT Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Outperform the market
Earnings are forecast to grow
BBOT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BBOT Street Sentiment is bullish and have positive views on the near-term outlook
BBOT has Low risk level

Overall Wall Street Rating
BBOT Stock IQ
Stock Insights
Strengths

Outperform the market

Upgraded on attractively valued

Earnings are forecast to grow
BBOT Trading Signals
BBOT is showing high volatility with an intraday swing of 5.23% (High: $8.85, Low: $8.41). This signals potential risk.
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
BBOT Stock trends
BBOT Stock performance
BBOT Stock analysis
BBOT investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.